# Evaluation of Marginal Integrity Using Bioactive Cement Incementation of Indirect Composite Blocks

> **NCT04557657** · PHASE1 · UNKNOWN · sponsor: **Cairo University** · enrollment: 40 (estimated)

## Conditions studied

- Resin Cement

## Interventions

- **DRUG:** Active bio Activa
- **DRUG:** Resin Cement

## Key facts

- **NCT ID:** NCT04557657
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2019-10-30
- **Final completion:** 2021-03
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2021-01-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04557657

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04557657, "Evaluation of Marginal Integrity Using Bioactive Cement Incementation of Indirect Composite Blocks". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04557657. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*